STOCK TITAN

Cantel Hires Michael Drexel to SVP and Chief Technology Officer

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags
management
Rhea-AI Summary

Cantel Medical Corp (NYSE: CMD) announced the hiring of Michael Drexel as Senior Vice President and Chief Technology Officer, effective October 1, 2020. Drexel, based in Plymouth, Minnesota, will lead the Global R&D team, focusing on enhancing customer value through product development and innovation. With over 25 years of experience, including roles at Fresenius Medical Care, he brings significant expertise in engineering and technical leadership. CEO George Fotiades expressed enthusiasm for Drexel's proven track record in driving continuous improvement in technology teams.

Positive
  • Hiring of Michael Drexel may lead to improved R&D and product development.
  • Drexel's extensive experience in medical device manufacturing can enhance technical capabilities.
  • Strengthened leadership in technology may boost investor confidence.
Negative
  • Potential continuity concerns as new leadership may require adjustment period.

LITTLE FALLS, N.J., Oct. 1, 2020 /PRNewswire/ -- CANTEL MEDICAL CORP (NYSE:CMD) announced today that Michael Drexel has been hired as Senior Vice President and Chief Technology Officer reporting to George Fotiades, Chief Executive Officer. Michael is based in Plymouth, Minnesota.

Mr. Drexel's primary responsibilities will include driving the overall vision for the R&D function, oversight and leadership for all projects related to research, and the development of new and existing products. He will assume leadership of the Global R&D team, driving technical excellence and providing clear focus on core competencies to maintain and enhance customer value of our products. In addition, he will build close partnerships with divisional and regional leaders to develop and execute on a thoughtful and comprehensive plan to effectively meet Cantel's objectives for current and future products.

Mr. Drexel has extensive leadership in product development including driving continuous improvement and developing management, engineering and technical talent. George Fotiades, Chief Executive Officer shared, "We are excited to welcome Michael to Cantel, he has a proven track record of successfully leading technology teams in the drive for continuous improvement in product development through to product launch."

With more than 25 years of experience across various manufacturing sectors, including medical device, Mr. Drexel brings strong leadership and technical acumen to the role. He most recently served as Senior Vice President Global R&D for Fresenius Medical Care, and prior to that was with Pentax Medical in various senior level roles. Mr. Drexel holds a PhD in Mechanical Engineering from Georgia Institute of Technology, a MS in Mechanical Engineering from the University of South Carolina, and a BS in Mechanical Engineering from Rensselaer Polytechnic Institute, New York.  

About Cantel Medical:
Cantel Medical is a leading global company dedicated to delivering innovative infection prevention products and services for patients, caregivers, and other healthcare providers which improve outcomes, enhance safety and help save lives. Our products include specialized medical device reprocessing systems for endoscopy and renal dialysis, advanced water purification equipment, sterilants, disinfectants and cleaners, sterility assurance monitoring products for hospitals and dental clinics, disposable infection control products primarily for dental and GI endoscopy markets, instruments and instrument reprocessing workflow systems serving the dental industry, dialysate concentrates, hollow fiber membrane filtration and separation products. Additionally, we provide technical service for our products.

For further information, visit www.cantelmedical.com.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/cantel-hires-michael-drexel-to-svp-and-chief-technology-officer-301139069.html

SOURCE Cantel Medical Corp.

FAQ

Who is the new Chief Technology Officer at Cantel Medical?

Michael Drexel has been appointed as the new Chief Technology Officer at Cantel Medical Corp.

What is Michael Drexel's background?

Michael Drexel has over 25 years of experience in product development and previously served as Senior VP Global R&D for Fresenius Medical Care.

What will Michael Drexel's role entail at Cantel Medical?

Drexel will oversee R&D, drive product development, and enhance customer value through innovation.

When was Michael Drexel hired by Cantel Medical?

Michael Drexel was hired on October 1, 2020.

How might Michael Drexel's hiring impact Cantel Medical's stock?

His extensive experience and leadership in R&D may positively influence investor sentiment and the company's growth prospects.

CMD

NYSE:CMD

CMD Rankings

CMD Latest News

CMD Stock Data

35.24M
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
US
Little Falls